Andrea T. Hooper

12.5k total citations · 4 hit papers
56 papers, 5.8k citations indexed

About

Andrea T. Hooper is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Andrea T. Hooper has authored 56 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 29 papers in Oncology and 10 papers in Hematology. Recurrent topics in Andrea T. Hooper's work include Angiogenesis and VEGF in Cancer (20 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Andrea T. Hooper is often cited by papers focused on Angiogenesis and VEGF in Cancer (20 papers), SARS-CoV-2 and COVID-19 Research (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Andrea T. Hooper collaborates with scholars based in United States, Germany and Netherlands. Andrea T. Hooper's co-authors include Shahin Rafii, Daniel J. Hicklin, Hans‐Georg Kopp, Marie Prewett, Scott T. Avecilla, Peter Böhlen, Jason M. Butler, Larry Witte, Rajiv Bassi and Lee M. Ellis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Andrea T. Hooper

54 papers receiving 5.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors

2008 731 citations Sergey V. Shmelkov, Jason M. Butler et al. Journal of Clinical Investigation profile →
Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

1999 557 citations Marie Prewett, Yiwen Li et al. PubMed profile →
Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells

2010 488 citations Jason M. Butler, Daniel J. Nolan et al. Cell stem cell profile →
Engraftment and Reconstitution of Hematopoiesis Is Dependent on VEGFR2-Mediated Regeneration of Sinusoidal Endothelial Cells

2009 467 citations Andrea T. Hooper, Jason M. Butler et al. Cell stem cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrea T. Hooper United States	32	2.8k	2.6k	1.2k	1.1k	1.0k	56	5.8k
Sonja Loges Germany	35	2.7k 1.0×	1.9k 0.7×	1.4k 1.2×	480 0.4×	926 0.9×	98	5.0k
Bronislaw Pytowski United States	37	3.5k 1.2×	3.6k 1.3×	741 0.6×	575 0.5×	790 0.8×	61	6.5k
Pieter A. van der Velden Netherlands	36	1.8k 0.6×	1.7k 0.6×	867 0.7×	2.9k 2.6×	994 1.0×	84	6.9k
Josef Vormoor Germany	35	3.2k 1.1×	3.5k 1.3×	1.2k 1.0×	2.7k 2.5×	1.5k 1.4×	117	7.8k
Daniel Dumont Canada	45	7.0k 2.5×	3.1k 1.2×	1.6k 1.3×	608 0.6×	1.0k 1.0×	112	10.0k
Girolamo Ranieri Italy	37	2.1k 0.7×	1.3k 0.5×	604 0.5×	522 0.5×	1.4k 1.3×	123	4.5k
Dieter K. Hossfeld Germany	36	2.6k 0.9×	1.8k 0.7×	762 0.6×	1.9k 1.7×	808 0.8×	165	6.1k
Benjamin Esterni France	32	1.4k 0.5×	2.2k 0.8×	1.0k 0.9×	1.0k 0.9×	380 0.4×	75	4.4k
Dirk Hose Germany	48	4.4k 1.5×	2.1k 0.8×	665 0.6×	3.5k 3.1×	1.2k 1.1×	210	6.8k
M. OʼReilly United States	14	3.7k 1.3×	1.9k 0.7×	2.2k 1.9×	347 0.3×	719 0.7×	30	6.0k

Countries citing papers authored by Andrea T. Hooper

Since Specialization

Citations

This map shows the geographic impact of Andrea T. Hooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea T. Hooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea T. Hooper more than expected).

Fields of papers citing papers by Andrea T. Hooper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea T. Hooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea T. Hooper. The network helps show where Andrea T. Hooper may publish in the future.

Co-authorship network of co-authors of Andrea T. Hooper

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea T. Hooper. A scholar is included among the top collaborators of Andrea T. Hooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea T. Hooper. Andrea T. Hooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Somersan-Karakaya, Selin, Eleftherios Mylonakis, Ernesto Oviedo‐Orta, et al.. (2023). Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial. Open Forum Infectious Diseases. 10(5). ofad211–ofad211. 1 indexed citations

Hooper, Andrea T., Selin Somersan-Karakaya, Shane McCarthy, et al.. (2022). Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies. mBio. 13(6). e0169922–e0169922. 7 indexed citations

Udata, Chandrasekhar, Sibo Jiang, Alison Forgie, et al.. (2020). Abstract 5508: BCMA-CD3 bispecific antibodies: A modeling framework to characterize kinetics of bispecific antibody, T cell, cytokines, and serum M-protein. Cancer Research. 80(16_Supplement). 5508–5508.

Ji, Changhua, Marc D. Roy, Jonathan Golas, et al.. (2019). Myocarditis in Cynomolgus Monkeys Following Treatment with Immune Checkpoint Inhibitors. Clinical Cancer Research. 25(15). 4735–4748. 91 indexed citations

Fisher, Timothy S., Andrea T. Hooper, Justin Lucas, et al.. (2017). A CD3-bispecific molecule targeting P-cadherin demonstrates T cell-mediated regression of established solid tumors in mice. Cancer Immunology Immunotherapy. 67(2). 247–259. 31 indexed citations

Westerweel, Peter E., Martin Teraa, Shahin Rafii, et al.. (2013). Impaired Endothelial Progenitor Cell Mobilization and Dysfunctional Bone Marrow Stroma in Diabetes Mellitus. PLoS ONE. 8(3). e60357–e60357. 54 indexed citations

Sapra, Puja, Andrea T. Hooper, Christopher J. O’Donnell, & Hans‐Peter Gerber. (2011). Investigational antibody drug conjugates for solid tumors. Expert Opinion on Investigational Drugs. 20(8). 1131–1149. 65 indexed citations

Butler, Jason M., Daniel J. Nolan, Eva Vertes, et al.. (2010). Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells. Cell stem cell. 6(3). 251–264. 488 indexed citations breakdown →

Kopp, Hans‐Georg, Andrea T. Hooper, Scott T. Avecilla, & Shahin Rafii. (2009). Functional Heterogeneity of the Bone Marrow Vascular Niche. Annals of the New York Academy of Sciences. 1176(1). 47–54. 49 indexed citations

10.

Swendeman, Steven, Karen Mendelson, Gisela Weskamp, et al.. (2008). VEGF-A Stimulates ADAM17-Dependent Shedding of VEGFR2 and Crosstalk Between VEGFR2 and ERK Signaling. Circulation Research. 103(9). 916–918. 138 indexed citations

11.

Kopp, Hans‐Georg, Andrea T. Hooper, Sergey V. Shmelkov, & Shahin Rafii. (2007). Beta-galactosidase staining on bone marrow. The osteoclast pitfall.. PubMed. 22(9). 971–6. 67 indexed citations

12.

Kopp, Hans‐Georg, Andrea T. Hooper, M. Johan Broekman, et al.. (2006). Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. Journal of Clinical Investigation. 116(12). 3277–3291. 80 indexed citations

13.

Chavala, Sai H., et al.. (2006). The MDM2 Inhibitor, Nutlin–3A, is Capable of Inhibiting Endothelial Cell Proliferation via p53 Mediated Apoptosis. Investigative Ophthalmology & Visual Science. 47(13). 5344–5344. 1 indexed citations

14.

Ruan, Jia, Elizabeth Hyjek, Pouneh Kermani, et al.. (2006). Magnitude of Stromal Hemangiogenesis Correlates with Histologic Subtype of Non–Hodgkin's Lymphoma. Clinical Cancer Research. 12(19). 5622–5631. 66 indexed citations

15.

Wu, Yan, Andrea T. Hooper, Zhaojing Zhong, et al.. (2006). The vascular endothelial growth factor receptor (VEGFR‐1) supports growth and survival of human breast carcinoma. International Journal of Cancer. 119(7). 1519–1529. 154 indexed citations

16.

Prewett, Marie, James R. Tonra, Rajiv Bassi, et al.. (2004). Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models. Cancer Research. 64. 1235–1235. 13 indexed citations

17.

Wu, Yan, Zhaojing Zhong, Huiling Li, et al.. (2004). A fully human monoclonal antibody against VEGFR-1 inhibits growth of human breast cancers. Cancer Research. 64. 694–695. 1 indexed citations

18.

Overholser, Jay, Marie Prewett, Andrea T. Hooper, Harlan W. Waksal, & Daniel J. Hicklin. (2000). Epidermal growth factor receptor blockade by antibody IMC‐C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice. Cancer. 89(1). 74–82. 8 indexed citations

19.

Overholser, Jay, Marie Prewett, Andrea T. Hooper, Harlan W. Waksal, & Daniel J. Hicklin. (2000). Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice. Cancer. 89(1). 74–82. 139 indexed citations

20.

Liao, Francesca‐Fang, Yiwen Li, William O’Connor, et al.. (2000). Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.. PubMed. 60(24). 6805–10. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact